• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达松弛素的纤维嵌合溶瘤腺病毒可延长荷瘤小鼠的生存期。

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.

作者信息

Ganesh Shanthi, Gonzalez Edick Melissa, Idamakanti Neeraja, Abramova Marina, Vanroey Melinda, Robinson Michael, Yun Chae-Ok, Jooss Karin

机构信息

Cell Genesys, Inc., South San Francisco, California 94080, USA.

出版信息

Cancer Res. 2007 May 1;67(9):4399-407. doi: 10.1158/0008-5472.CAN-06-4260.

DOI:10.1158/0008-5472.CAN-06-4260
PMID:17483354
Abstract

Selective replication of oncolytic viruses in tumor cells provides a promising approach for the treatment of human cancers. One of the limitations observed with oncolytic viruses currently used in the treatment of solid tumors is the inefficient spread of virus throughout the tumor mass following intratumoral injection. Data are presented showing that oncolytic adenoviruses expressing the relaxin gene and containing an Ad5/Ad35 chimeric fiber showed significantly enhanced transduction and increased virus spread throughout the tumor when compared with non-relaxin-expressing, Ad5-based viruses. The increased spread of such viruses throughout tumors correlated well with improved antitumor efficacy and overall survival in two highly metastatic tumor models. Furthermore, nonreplicating viruses expressing relaxin did not increase metastases, suggesting that high level expression of relaxin will not enhance metastatic spread of tumors. In summary, the data show that relaxin may play a role in rearranging matrix components within tumors, which helps recombinant oncolytic adenoviruses to spread effectively throughout the tumor mass and thereby increase the extent of viral replication within the tumor. Expressing relaxin from Ad5/Ad35 fiber chimeric adenoviruses may prove a potent and novel approach to treating patients with cancer.

摘要

溶瘤病毒在肿瘤细胞中的选择性复制为人类癌症的治疗提供了一种很有前景的方法。目前用于实体瘤治疗的溶瘤病毒存在的局限性之一是瘤内注射后病毒在整个肿瘤块中的传播效率低下。所呈现的数据表明,与不表达松弛素的基于Ad5的病毒相比,表达松弛素基因且含有Ad5/Ad35嵌合纤维的溶瘤腺病毒显示出显著增强的转导作用,并增加了病毒在整个肿瘤中的传播。在两种高转移性肿瘤模型中,此类病毒在肿瘤中的传播增加与抗肿瘤疗效的改善和总体生存期的延长密切相关。此外,表达松弛素的非复制型病毒并未增加转移,这表明松弛素的高水平表达不会增强肿瘤的转移扩散。总之,数据表明松弛素可能在重新排列肿瘤内的基质成分中发挥作用,这有助于重组溶瘤腺病毒在整个肿瘤块中有效传播,从而增加病毒在肿瘤内的复制程度。从Ad5/Ad35纤维嵌合腺病毒表达松弛素可能是一种治疗癌症患者的有效且新颖的方法。

相似文献

1
Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.表达松弛素的纤维嵌合溶瘤腺病毒可延长荷瘤小鼠的生存期。
Cancer Res. 2007 May 1;67(9):4399-407. doi: 10.1158/0008-5472.CAN-06-4260.
2
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.在转移性肿瘤模型中,瘤内联合给予透明质酸酶和溶瘤腺病毒可增强病毒效力。
Clin Cancer Res. 2008 Jun 15;14(12):3933-41. doi: 10.1158/1078-0432.CCR-07-4732.
3
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.靶向肿瘤腺病毒的松弛素表达及其在肿瘤内的扩散、凋亡诱导和疗效。
J Natl Cancer Inst. 2006 Oct 18;98(20):1482-93. doi: 10.1093/jnci/djj397.
4
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.一种衣壳修饰的、条件性复制的表达TRAIL的溶瘤腺病毒载体在人胶质母细胞瘤模型中导致增强的癌细胞杀伤作用。
Cancer Res. 2007 Sep 15;67(18):8783-90. doi: 10.1158/0008-5472.CAN-07-0357.
5
Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.使用Ad5/35纤维嵌合型条件复制腺病毒改善胶质母细胞瘤治疗
J Gene Med. 2007 Sep;9(9):764-78. doi: 10.1002/jgm.1076.
6
Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.在头颈部癌临床前模型中,放疗或顺铂联合治疗可增强Ad5/35嵌合溶瘤腺病毒的效力。
Cancer Gene Ther. 2009 May;16(5):383-92. doi: 10.1038/cgt.2008.90. Epub 2008 Nov 14.
7
Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.在具有复制能力的腺病毒背景下抗凋亡蛋白与肿瘤坏死因子的功能相互作用。
Gene Ther. 2005 Sep;12(17):1333-46. doi: 10.1038/sj.gt.3302555.
8
A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.一种用于生成携带一个或两个转基因的溶瘤腺病毒载体的简化系统。
Cancer Gene Ther. 2008 Mar;15(3):173-82. doi: 10.1038/sj.cgt.7701105. Epub 2007 Dec 21.
9
Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.利用纤维扣环上展示随机肽的腺病毒文库进行胰腺癌的溶瘤病毒治疗。
Gene Ther. 2009 May;16(5):669-80. doi: 10.1038/gt.2009.1. Epub 2009 Feb 19.
10
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer.单次静脉注射OAS403(一种依赖人类癌症中两种常见改变的溶瘤腺病毒)的抗肿瘤疗效和肿瘤选择性复制
Cancer Gene Ther. 2004 Aug;11(8):555-69. doi: 10.1038/sj.cgt.7700735.

引用本文的文献

1
The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges.松弛素样肽家族对肿瘤进展的多种影响:潜在机遇与新挑战
Heliyon. 2024 Jan 10;10(2):e24463. doi: 10.1016/j.heliyon.2024.e24463. eCollection 2024 Jan 30.
2
Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia.程序性死亡配体(PD-L1)、表皮生长因子(EGF)、松弛素和基质金属蛋白酶-3(MMP3):犬乳腺肿瘤恶性肿瘤的潜在生物标志物。
Int J Mol Sci. 2024 Jan 18;25(2):1170. doi: 10.3390/ijms25021170.
3
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective.
溶瘤病毒工程与应用:癌症免疫治疗视角
Viruses. 2023 Jul 28;15(8):1645. doi: 10.3390/v15081645.
4
Genetic Modifications That Expand Oncolytic Virus Potency.增强溶瘤病毒效力的基因改造。
Front Mol Biosci. 2022 Jan 26;9:831091. doi: 10.3389/fmolb.2022.831091. eCollection 2022.
5
Delivery of therapeutic oligonucleotides in nanoscale.纳米级治疗性寡核苷酸的递送
Bioact Mater. 2021 Jun 12;7:292-323. doi: 10.1016/j.bioactmat.2021.05.038. eCollection 2022 Jan.
6
Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.利用细胞融合蛋白增强腺病毒载体疗效作为一种抗癌治疗方法。
Cancer Gene Ther. 2021 Aug;28(7-8):745-756. doi: 10.1038/s41417-020-0192-9. Epub 2020 Jul 1.
7
Antifibrotic therapy to normalize the tumor microenvironment.抗纤维化治疗使肿瘤微环境正常化。
J Transl Med. 2020 May 20;18(1):207. doi: 10.1186/s12967-020-02376-y.
8
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses.转基因位置、转录控制元件及武装溶瘤腺病毒中转基因特征的作用
Cancers (Basel). 2020 Apr 23;12(4):1034. doi: 10.3390/cancers12041034.
9
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models.溶瘤腺病毒 VCN-01 可增强原始神经外胚层肿瘤模型的抗肿瘤作用。
Sci Rep. 2019 Oct 7;9(1):14368. doi: 10.1038/s41598-019-51014-1.
10
Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model.硼替佐米-OV疗法与抗侵袭策略在胶质母细胞瘤中的协同效应:一个数学模型
Cancers (Basel). 2019 Feb 13;11(2):215. doi: 10.3390/cancers11020215.